News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

EU Agency Due To Give Verdict On Teva Pharmaceutical Industries Limited (TEVA) MS Pill This Week



12/17/2013 8:19:34 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

European regulators are due to decide this week whether or not to recommend approval of a new multiple sclerosis pill from Teva Pharmaceutical Industries, according to a document published on Tuesday. The European Medicines Agency, which has started publishing agendas for its scientific meetings, listed Teva's laquinimod among new medicines to be considered at the December 16-19 meeting of the Committee for Medicinal Products for Human Use (CHMP). Decisions from the monthly meetings of the CHMP are normally made public on the following Friday, which would be December 20.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at Globes Online


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES